Strategies for Assessing and Addressing Confounding
Kaplan-Meier Approach
What are Estimates?
Theory of Attribution I: Correspondent Inference Theory
Causality in Epidemiology
Censoring Survival Data
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Nov 21, 2025

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits
Published on: September 27, 2019
Yongming Qu1, Junxiang Luo2, Stephen J Ruberg3
1Department of Biometrics, Eli Lilly and Company, Indianapolis, Indiana, USA.
This study introduces tripartite estimands to analyze clinical trial data, addressing intercurrent events and missing values. These estimands provide a comprehensive understanding of treatment effects, including adverse events, lack of efficacy, and adherence to treatment.
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
06:45Task Interruption and Resumption Paradigm for Testing the Activation and Pursuit of an Abstract Thinking Goal
Published on: April 18, 2017
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: